Processa Pharmaceuticals, Inc. Due to Related Parties, Current
Processa Pharmaceuticals, Inc. (PCSA) had Due to Related Parties, Current of $51 as of 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Notes
us-gaap:DueToRelatedPartiesCurrent · last filed 2023-03-30
- 2022-12-31: Due to Related Parties, Current $51.00.
- 2021-12-31: Due to Related Parties, Current $1.77K.
- 2021-06-30: Due to Related Parties, Current $11.74K.
- 2021-03-31: Due to Related Parties, Current $41.26K.
| Period end | Due to Related Parties, Current |
|---|---|
| 2022-12-31 | $51.00 10-K · filed 2023-03-30 |
| 2021-12-31 | $1.77K 10-K · filed 2023-03-30 |
| 2021-06-30 | $11.74K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $41.26K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $69.86K 10-K · filed 2022-03-30 |
| 2020-09-30 | $110.80K 10-Q · filed 2020-11-12 |
| 2019-12-31 | $316.00 10-K · filed 2021-03-25 |
| 2019-09-30 | $25.73K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.34K 10-Q · filed 2019-08-14 |
| 2018-09-30 | $100.00 10-Q · filed 2018-11-14 |
| 2018-06-30 | $1.12K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $436.00 10-Q · filed 2018-05-21 |
| 2017-12-31 | $436.00 10-K/A · filed 2019-04-08 |
| 2016-12-31 | $95.00 10-K · filed 2018-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |